Joint Annual Scientific Meeting
New Zealand Rheumatology Association
and Australian Rheumatology Association
with the Rheumatology Health Professionals Association
Menu

Speakers

International guests include Professor Georg Schett (Germany) speaking on osteoimmunology and joint damage in arthritis, Professor Arthur Kavanaugh (US) on psoriatic arthritis and therapeutic targets in rheumatoid arthritis, Dr Peter Balint (Hungary) on musculoskeletal ultrasound in rheumatology practice, Dr Madelaine Rooney (Ireland) on paediatric rheumatology and Dr Kori Dewing (US) on the role of the nurse practitioner in rheumatology practice.

A Kacananaugh Professor Arthur Kavanaugh, MD
Professor of Medicine at the University of California, San Diego (UCSD) School of Medicine
Director of the Center for Innovative Therapy in the UCSD Division of Rheumatology, Allergy, and Immunology

Dr Arthur Kavanaugh is Professor of Medicine at the University of California, San Diego (UCSD) School of Medicine. In addition, he is the Director of the Center for Innovative Therapy in the UCSD Division of Rheumatology, Allergy, and Immunology.

Dr Kavanaugh earned his BS in biology at the Massachusetts Institute of Technology in Cambridge, Massachusetts and his MD at Saint Louis University School of Medicine in Saint Louis, Missouri. He completed a residency in Internal Medicine and then a fellowship in Clinical Immunology/Allergy at the Baylor College of Medicine in Houston, Texas. Dr Kavanaugh also completed a Rheumatology fellowship at the University of Texas Southwestern Medical School in Dallas. In 1990, he joined the faculty at UT Southwestern> in 1999 he joined the Rheumatology, Allergy, Immunology Division at UCSD, where he has been since that time.

Dr Kavanaugh has authored more than 450 publications. He is on the editorial board for several journals, and has served as peer reviewer for many scientific journals. Dr Kavanaugh is a fellow of the American Academy of Allergy, Asthma, and Immunology (AAAAI), and the American College of Rheumatology (ACR). He has been a member of and chaired a number of committees in these organizations.

Dr Kavanaugh’s main research interest has been in clinical research, particularly translational aspects of rheumatology research. This has included work delineating the pathophysiology of rheumatic diseases as well as defining changes associated with novel immunomodulatory therapies. The focus of many clinical projects has been rheumatoid arthritis and psoriatic arthritis, but Dr Kavanaugh has conducted many studies in other autoimmune conditions, including systemic lupus erythematosus (SLE), ankylosing spondylitis, inflammatory bowel disease, and others. In addition, he has performed studies focusing on novel imaging methods and also clinical outcomes.

Dr Kavanaugh has been involved with helping to create guidelines for the treatment and optimal care of patients with rheumatic diseases. He was involved with the formation of GRAPPA (Group for Research and Assessment of Psoriasis and Psoriatic Arthritis) and remains on the steering committee. Dr Kavanaugh has been a board member of CORRONA (Consortium Of Rheumatology Researchers Of North America) since its inception.

G SchettProfessor Georg A. Schett, MD
University Hospital Erlangen, Germany

Georg Schett is professor of Internal Medicine and since 2006, head of the Department of Internal Medicine 3 - Rheumatology and Immunology at University Hospital Erlangen, Friedrich-Alexander University Erlangen (Nuremberg/Germany).

Professor Schett graduated from the University of Innsbruck (Austria) in 1994. After his graduation from medical school, he worked as a scientist at the Institute of BioMedical Aging Research of the Austrian Academy of Science in Innsbruck. Two years later, he joined the Department of Medicine at the University of Vienna, where he completed his postgraduate training in Internal Medicine and subsequently in Rheumatology. In 2003 he was promoted to professor of Internal Medicine. Before accepting his position as the chair of the Department of Internal Medicine 3 in Erlangen, he worked as a scientist in the United States of America for one year.

Georg Schett’s scientific work includes a broad spectrum of clinical and immunological issues, particularly the molecular basics of immune-inflammatory diseases. Initially, he investigated the immunology of atherosclerosis and focused on antibody-mediated endothelial cell damage. His research work lead to the understanding of the phenomenon of LE-cells in 2007. He was awarded the renowned START-award in 2002 and established a research group for arthritis in Vienna. In 2008, he initiated in collaboration with colleagues the priority program Immunobone in Germany, funded by the German’s Research Foundation (DFG). Immunobone aims to elucidate, the interactions between the skeletal- and the immune systems. Since 2015, Prof. Schett leads the DFG collaborative research center, “Checkpoints for Resolution of Inflammation” in Erlangen. Additionally, he coordinates the project Metarthros funded by the Federal Ministry of Education and Research, which investigates the impact of the metabolism on arthritis. His scientific work has been honoured with several awards, including the Carol-Nachmann Award from Wiesbaden. He has published over 500 peer-reviewed papers.

Dr Peter Balint (Hungary)

Peter V. Balint became a physician at Semmelweis University in Budapest. He has been working for the National Institute of Rheumatology and Physiotherapy since 1989. Currently, he is the Head of Department at 3rd Rheumatology Department and Professor (honoris causa) of Semmelweis University in Budapest.

 In 1991 he graduated in rheumatology and physiotherapy and obtained board certification. He has a particular interest in musculoskeletal ultrasonography since 1991.  He graduated from the University of Glasgow for his PhD work in 2002 (Ultrasound imaging in joint and soft tissue inflammation) under supervision of Prof. Roger D. Sturrock. He became a Fellow of the Royal College of Physicians and Surgeons (Glasgow) in 2007. Since 1990 he has published more than 150 papers, 20 books and book chapters, has been an invited speaker for more than 70 international meeting, and organizer and convenor of several musculoskeletal ultrasound courses.  He is also a member of EULAR Standing Committee on Musculoskeletal Imaging, EULAR/ OMERACT Ultrasound Special Interest GroupUSSONAR- MSSK, EFSUMB, GRAPPA and Association of Hungarian Rheumatologists. He is a reviewer for several international rheumatology journals in the field of sonography and is the editor of the Imaging Section of Hungarian Rheumatology. He became a co-chairman with Tony Reginato of ACR Ultrasound Study Group in 2011.  He defended his habilitation thesis “ The role of ultrasonography in assessing synovitis, tendon damage and cartilage destruction in rheumatoid arthritis” in 2014 at the University of Debrecen, and the Senate of Semmelweis University elected him Honoris causa Professor in 2015. His unit was elected as EULAR Imaging Excellence Centre between 2015-2020.

Dr Madeleine Rooney (Ireland)

Dr Madeleine Rooney qualified from Queens University Belfast in 1980. She undertook her doctorate with Prof Barry Bresnihan in Dublin before moving to Edinburgh to complete her postgraduate training. She undertook a 2 year Wellcome research fellowship with Dr Ann Maire Prieur, Hopital Necker in Paris before taking up her post as MRC consultant in Paediatric Rheumatology in Northwick Park Hospital and subsequently Great Ormond Street Hospital London.

She returned to N Ireland in 1999 ultimately to be appointed as the provinces first paediatric rheumatologist.  She is currently Senior lecturer in the Centre for Experimental Medicine Queens University of Belfast.

Her research interests include the use of ultrasound in the diagnosis and management of childhood rheumatic diseases. She has undertaken multicentre clinical trials in disease management in JIA. She is currently investigating a novel method of drug delivery for children requiring disease modifying drugs.

She has established a longitudinal study into disease outcome in JIA and has pioneered the use of a proteomic approach to predict the outcome in JIA including uveitis and has published widely in this discipline.

She is passionate about young people’s access to education whilst coping with chronic disease and the Chair of Board Governors Belfast Hospital School Which provides flexible education in the Greater Belfast area.

She is on the executive committee of MCRN/Arthritis Research UK Paediatric Rheumatology Clinical Studies Group, and the British Society for Paediatric and Adolescent Rheumatology.

K DewingDr Kori Dewing (US)

Kori Dewing, ANP-BC, DNP, ARNP is a doctoral trained rheumatology nurse practitioner from the United States. She received her graduate training at the University of Washington where she received the DNP Graduate Student of the Year award for her doctoral research in improving bone density screening rates within her health care system at Virginia Mason Medical Center. Dr. Dewing has been working in rheumatology for the last 14 years and serves as an Affiliate Assistant Professor in the Department of Biobehavioral Nursing and Health Systems at the University of Washington. Additionally, Dr. Dewing has assumed numerous leadership positions within the American College of Rheumatology/Association of Rheumatology Health Professionals, and received the ARHP President’s Award in 2009 for her work in developing training curriculum and hands-on skills training courses designed for nurse practitioners entering into the rheumatology workforce. Dr. Dewing is the author of several peer reviewed journal articles and has lectured on numerous rheumatologic topics nationally. Early in her career, Dr. Dewing founded the Washington Rheumatology ARNP/PAs (WRAP) non-profit organization, dedicated to providing educational support to nurse practitioners working locally in rheumatology. She is the proud mother of two school age children and enjoys teaching health education in their unique parent cooperative elementary school.

Other Speakers

Assoc Prof Mark Bolland, University of Auckland

Prof Keith Petrie, University of Auckland

Prof Rachelle Buchbinder, Monash University

Dr Helen Keen, University of Western Australia

Assoc Prof Anthony Doyle, Auckland District Health Board and University of Auckland

Prof Larry Chamley, University of Auckland

Prof Catherine Hill, The Queen Elizabeth Hospital

Dr Ravi Suppiah, Auckland District Health Board

Dr Angela Brenton-Rule, Auckland University of Technology

Prof Keith Rome, Auckland University of Technology

Dr John O'Donnell, Canterbury District Health Board

Prof Tony Merriman, University of Otago

Prof Lisa Stamp, University of Otago

Prof Edward Gane, Auckland District Health Board

Prof Jillian Cornish, University of Auckland

Susan Reid, Health Literacy New Zealand

Dr Emma Best, Auckland District Health Board and University of Auckland

Dr Bridget Farrant, Auckland District Health Board

Assoc Prof Haxby Abbott, University of Otago